The global bovine high mountain disease drug market is expected to grow at a CAGR of 5.5% during the forecast period, to reach USD 1.2 billion by 2030. The growth of this market is driven by the increasing number of cattle in developing countries and the rising demand for beef in these regions. The increase in demand for beef has led to an increase in the number of cattle being raised on high mountain ranges, which are more susceptible to diseases such as bovine high mountain disease (BHMD). This has led to an increased need for BHMD drugs, which are used as a preventive measure against BHMD and other diseases that affect cattle on high mountains ranges. Diuretics segment accounted for over 50% share of the global bovine high mountain disease drug market in 2017 and is expected to maintain its dominance throughout the forecast period due to their effectiveness against BHMD and other diseases that affect cattle on high mountains ranges. Antibiotics segment accounted for over 30% share of the global bovine high mountain disease drug market in 2017 and is expected to grow at a CAGR of 6% during 2018-2030 due its effectiveness against bacterial infections caused by E coli, Salmonella spp., Klebsiella spp., Staphylococcus spp., Streptococcus spp., Pseudomonas aeruginosa, Proteus mirabilis, Enterobacter cloacae among others. Appetite stimulators segment accounted for over 10% share of the global bovine high mountain disease drug market in 2017 and is expected grow at a CAGR between 4-6%.
Some Of The Growth Factors Of This Market:
- Increasing prevalence of Bovine High Mountain Disease Drug in cattle population is one of the major factors driving the growth of this market.
- Increasing demand for meat and dairy products from emerging economies such as China, India, and Brazil is also driving the growth of this market.
- Lack of awareness about Bovine High Mountain Disease Drug among farmers and veterinarians is restraining the growth of this market to some extent.
- Increasing number of research activities in developing new drugs for treatment are also expected to fuel the growth rate during forecast period.
Industry Growth Insights published a new data on “Bovine High Mountain Disease Drug Market”. The research report is titled “Bovine High Mountain Disease Drug Market research by Types (Diuretics, Antibiotics, Appetite Stimulators, Others, Bovine High Mountain Disease Dru), By Applications (Veterinary Hospitals, Veterinary Clinics, Others), By Players/Companies Zoetis, Bayer, Eli Lilly, Dechra Pharmaceuticals, Merck, Bovine High Mountain Disease Dru”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Bovine High Mountain Disease Drug Market Research Report
By Type
Diuretics, Antibiotics, Appetite Stimulators, Others, Bovine High Mountain Disease Dru
By Application
Veterinary Hospitals, Veterinary Clinics, Others
By Companies
Zoetis, Bayer, Eli Lilly, Dechra Pharmaceuticals, Merck, Bovine High Mountain Disease Dru
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Bovine High Mountain Disease Drug Market Report Segments:
The global Bovine High Mountain Disease Drug market is segmented on the basis of:
Types
Diuretics, Antibiotics, Appetite Stimulators, Others, Bovine High Mountain Disease Dru
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Veterinary Hospitals, Veterinary Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Zoetis
- Bayer
- Eli Lilly
- Dechra Pharmaceuticals
- Merck
- Bovine High Mountain Disease Dru
Highlights of The Bovine High Mountain Disease Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Diuretics
- Antibiotics
- Appetite Stimulators
- Others
- Bovine High Mountain Disease Dru
- By Application:
- Veterinary Hospitals
- Veterinary Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bovine High Mountain Disease Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bovine high mountain disease drug is a medication used to treat bovine high mountain disease.
Some of the key players operating in the bovine high mountain disease drug market are Zoetis, Bayer, Eli Lilly, Dechra Pharmaceuticals, Merck, Bovine High Mountain Disease Dru.
The bovine high mountain disease drug market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Bovine High Mountain Disease Drug Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Bovine High Mountain Disease Drug Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Bovine High Mountain Disease Drug Market - Supply Chain
4.5. Global Bovine High Mountain Disease Drug Market Forecast
4.5.1. Bovine High Mountain Disease Drug Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Bovine High Mountain Disease Drug Market Size (000 Units) and Y-o-Y Growth
4.5.3. Bovine High Mountain Disease Drug Market Absolute $ Opportunity
5. Global Bovine High Mountain Disease Drug Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Bovine High Mountain Disease Drug Market Size and Volume Forecast by Type
5.3.1. Diuretics
5.3.2. Antibiotics
5.3.3. Appetite Stimulators
5.3.4. Others
5.3.5. Bovine High Mountain Disease Dru
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Bovine High Mountain Disease Drug Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Bovine High Mountain Disease Drug Market Size and Volume Forecast by Application
6.3.1. Veterinary Hospitals
6.3.2. Veterinary Clinics
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Bovine High Mountain Disease Drug Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Bovine High Mountain Disease Drug Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Bovine High Mountain Disease Drug Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Bovine High Mountain Disease Drug Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Bovine High Mountain Disease Drug Demand Share Forecast, 2019-2026
9. North America Bovine High Mountain Disease Drug Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Bovine High Mountain Disease Drug Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Bovine High Mountain Disease Drug Market Size and Volume Forecast by Application
9.4.1. Veterinary Hospitals
9.4.2. Veterinary Clinics
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Bovine High Mountain Disease Drug Market Size and Volume Forecast by Type
9.7.1. Diuretics
9.7.2. Antibiotics
9.7.3. Appetite Stimulators
9.7.4. Others
9.7.5. Bovine High Mountain Disease Dru
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Bovine High Mountain Disease Drug Demand Share Forecast, 2019-2026
10. Latin America Bovine High Mountain Disease Drug Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Bovine High Mountain Disease Drug Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Bovine High Mountain Disease Drug Market Size and Volume Forecast by Application
10.4.1. Veterinary Hospitals
10.4.2. Veterinary Clinics
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Bovine High Mountain Disease Drug Market Size and Volume Forecast by Type
10.7.1. Diuretics
10.7.2. Antibiotics
10.7.3. Appetite Stimulators
10.7.4. Others
10.7.5. Bovine High Mountain Disease Dru
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Bovine High Mountain Disease Drug Demand Share Forecast, 2019-2026
11. Europe Bovine High Mountain Disease Drug Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Bovine High Mountain Disease Drug Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Bovine High Mountain Disease Drug Market Size and Volume Forecast by Application
11.4.1. Veterinary Hospitals
11.4.2. Veterinary Clinics
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Bovine High Mountain Disease Drug Market Size and Volume Forecast by Type
11.7.1. Diuretics
11.7.2. Antibiotis
11.7.3. Appetite Stimulators
11.7.4. Others
11.7.5. Bovine High Mountain Disease Dru
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Bovine High Mountain Disease Drug Demand Share, 2019-2026
12. Asia Pacific Bovine High Mountain Disease Drug Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Bovine High Mountain Disease Drug Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Bovine High Mountain Disease Drug Market Size and Volume Forecast by Application
12.4.1. Veterinary Hospitals
12.4.2. Veterinary Clinics
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Bovine High Mountain Disease Drug Market Size and Volume Forecast by Type
12.7.1. Diuretics
12.7.2. Antibiotics
12.7.3. Appetite Stimulators
12.7.4. Others
12.7.5. Bovine High Mountain Disease Dru
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Bovine High Mountain Disease Drug Demand Share, 2019-2026
13. Middle East & Africa Bovine High Mountain Disease Drug Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Bovine High Mountain Disease Drug Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Bovine High Mountain Disease Drug Market Size and Volume Forecast by Application
13.4.1. Veterinary Hospitals
13.4.2. Veterinary Clinics
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Bovine High Mountain Disease Drug Market Size and Volume Forecast by Type
13.7.1. Diuretics
13.7.2. Antibiotics
13.7.3. Appetite Stimulators
13.7.4. Others
13.7.5. Bovine High Mountain Disease Dru
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Bovine High Mountain Disease Drug Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Bovine High Mountain Disease Drug Market: Market Share Analysis
14.2. Bovine High Mountain Disease Drug Distributors and Customers
14.3. Bovine High Mountain Disease Drug Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Zoetis
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Bayer
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Eli Lilly
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Dechra Pharmaceuticals
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Merck
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Bovine High Mountain Disease Dru
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook